Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-645-2 | CAS number: 85-98-3
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Ethylcentralite did not demonstrate mutagenic activity in any of the tests conducted. Ethylcentralite was not mutagenic in Salmonella Mutagenicity Test using strains TA97, TA98, TA100 and TA1535 or in Bacterial Reverse Mutation Test (acc. to EU method B.13/14 analogous to the OECD TG 471) both in the presence and absence of S9 metabolic activation and in In vitro Mammalian Chromosome Aberration Test on the human peripheral blood lymphocytes without and with metabolic activation and finally Ethylcentralite was not even mutagenic in the In vitro Mammalian Cell Gene Mutation Assay (Thymidine Kinase Locus/TK+/-) in mouse lymphoma L5178Y cells without and with metabolic activation.
Justification for selection of
genetic toxicity endpoint
No study was selected, all studies were negative.
Short description of key information:
Ethyl centralit was tested for mutagenicity:
- in Salmonella typhimurium, using a
preincubation protocol. Test was performed in the absence of exogenous
metabolic activation, and in the presence of liver S-9 from
Aroclor-induced male Sprague-Dawley rats and Syrian hamsters,
- in Bacterial Reverse Mutation Test
Four indicator Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and one indicator Escherichia coli WP2 uvrA strain were used with and without metabolic activation using a supernatant of rat liver S9
- in vitro Mammalian Chromosome Aberration Test on the human peripheral blood lymphocytes without and with metabolic activation,
- in vitro Mammalian Cell Gene Mutation Assay (Thymidine Kinase Locus/TK+/-) in mouse lymphoma L5178Y cells without and with metabolic activation
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the available data, the substance is not classified for genetic toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
